Altered Homeostatic Functions in Reactive Astrocytes and Their Potential as a Therapeutic Target After Brain Ischemic Injury

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|23|33|5056-5074

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.33, 2018-01, pp. : 5056-5074

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GLT-1 Upregulation as a Potential Therapeutic Target for Ischemic Brain Injury

By  

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 5045-5055

Bentham Science Publishers

Access to resources Recommend Favorite

Superoxide and Post-Ischemic Liver Injury: Potential Therapeutic Target for Liver Transplantation

By  

Current Medicinal Chemistry, Vol. 10, Iss. 24, 2003-12 ,pp. : 2661-2667

Bentham Science Publishers

Access to resources Recommend Favorite

Clusterin may be a therapeutic target for preventing brain injury after hypoxia-ischaemia

By  

Inpharma, Vol. 1, Iss. 1287, 2001-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Osteopontin as a Potential Therapeutic Target for Ischemic Stroke

By  

Current Drug Delivery, Vol. 14, Iss. 6, 2017-09 ,pp. : 766-772

Bentham Science Publishers

Access to resources Recommend Favorite

Eph/ephrin Signaling as a Potential Therapeutic Target After Central Nervous System Injury

By  

Current Pharmaceutical Design, Vol. 13, Iss. 24, 2007-08 ,pp. : 2507-2518

Bentham Science Publishers

Access to resources Recommend Favorite